bcl-2 expression is reciprocal to p53 and c-myc expression in metastatic human colorectal cancer

By Popescu R.A.   Lohri A.   de Kant E.   Thiede C.   Reuter J.   Herrmann R.   Rochlitz C.F.  

European Journal of Cancer, Vol. 34, Iss. 8, 1998-07 ,pp. : 1268-1273

Elsevier

Access to resources Recommend Favorite

Cetuximab treatment for metastatic colorectal cancer with KRAS p.G13D mutations improves progression-free survival

By                                

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1053-1057

Science Publishers

Access to resources Recommend Favorite

Possible prognostic significance of p53 immunoreactive status of hepatic colorectal cancer metastases following surgical resection

By Pocard M.   Paradis V.   Adam R.   Reynes M.   Bismuth H.  

European Journal of Cancer, Vol. 34, Iss. 4, 1998-03 ,pp. : 594-595

Elsevier

Access to resources Recommend Favorite

p53 codon 72 polymorphism as a progression index for bladder cancer

By Lin Hung-Yu   Huang Chun-Hsiung   Yu Tsan-Jung   Wu Wen-Jen   Yang Ming-Chang   Lung For-Wey  

Oncology Reports, Vol. 27, Iss. 4, 2012-04 ,pp. : 1193-1199

Spandidos Publications

Access to resources Recommend Favorite

Prognostic Significance of Cytoplasmic p53 Overexpression in Colorectal Cancer. An Immunohistochemical Analysis

By Flamini G.   Curigliano G.   Ratto C.   Astone A.   Ferretti G.   Nucera P.   Sofo L.   Sgambato A.   Boninsegna A.   Crucitti F.   Cittadini A.  

European Journal of Cancer, Vol. 32, Iss. 5, 1996-05 ,pp. : 802-806

Elsevier

Access to resources Recommend Favorite